MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway

Area of Science:

• Endocrinology
• Molecular Biology
• Pathology

Background:

• Polycystic ovary syndrome (PCOS) is a common endocrine disorder.
• The pathogenesis of PCOS involves complex hormonal and cellular mechanisms.
• Macrophage migration inhibitory factor (MIF) and the MAPK signaling pathway are implicated in inflammatory and reproductive processes.

Purpose of the Study:

• To investigate the role of macrophage migration inhibitory factor (MIF) in a rat model of polycystic ovary syndrome (PCOS).
• To examine the correlation between MIF expression, cytokinesis, and the mitogen-activated protein kinase (MAPK) signaling pathway in the ovaries of PCOS rats.
• To assess the impact of dehydroepiandrosterone (DHEA) and high-fat diet (HFD) on these molecular markers in PCOS.

Main Methods:

• Establishment of a PCOS rat model using dehydroepiandrosterone (DHEA).
• Grouping of rats into control, PCOS, and PCOS with high-fat diet (HFD) groups.
• Serum hormone analysis (RIA), immunohistochemical staining for MIF, and Western blotting for MIF, p-JNK, and p-p38 expression in ovarian tissue.

Main Results:

• PCOS and PCOS with HFD groups exhibited significantly elevated serum testosterone, LH, LH/FSH ratio, fasting insulin, and HOMA IR compared to controls.
• Expression levels of MIF, p-JNK, and p-p38 were significantly higher in the ovaries of PCOS and PCOS with HFD rats compared to controls.
• No significant differences in hormonal profiles or molecular marker expression were observed between the PCOS and PCOS with HFD groups.

Conclusions:

• Macrophage migration inhibitory factor (MIF) may play a role in the pathogenesis of PCOS.
• The MAPK signaling pathway (specifically JNK and p38) is activated in the ovaries of DHEA-induced PCOS rats.
• MIF might contribute to PCOS development by influencing the MAPK signaling pathway in the ovarian context.